| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 712 | 2021 |
| The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis T Kurita, S Yasuda, K Oba, T Odani, M Kono, K Otomo, Y Fujieda, K Oku, ... Rheumatology 54 (1), 39-44, 2015 | 159 | 2015 |
| Predominant prevalence of arterial thrombosis in Japanese patients with antiphospholipid syndrome Y Fujieda, T Atsumi, O Amengual, T Odani, K Otomo, M Kato, K Oku, ... Lupus 21 (14), 1506-1514, 2012 | 65 | 2012 |
| Hepatitis B virus reactivation by immunosuppressive therapy in patients with autoimmune diseases: risk analysis in hepatitis B surface antigen-negative cases M Kato, T Atsumi, T Kurita, T Odani, Y Fujieda, K Otomo, T Horita, ... The Journal of rheumatology 38 (10), 2209-2214, 2011 | 58 | 2011 |
| DOCK2 is involved in the host genetics and biology of severe COVID-19 H Namkoong, R Edahiro, T Takano, H Nishihara, Y Shirai, K Sonehara, ... Nature 609 (7928), 754-760, 2022 | 53 | 2022 |
| Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded … M Utsunomiya, H Dobashi, T Odani, K Saito, N Yokogawa, K Nagasaka, ... Arthritis research & therapy 19 (1), 1-10, 2017 | 52 | 2017 |
| LAMP3 induces apoptosis and autoantigen release in Sjögren’s syndrome patients T Tanaka, BM Warner, T Odani, Y Ji, YQ Mo, H Nakamura, SI Jang, H Yin, ... Scientific Reports 10 (1), 1-17, 2020 | 47 | 2020 |
| Targeting primary Sjögren’s syndrome T Odani, JA Chiorini Modern Rheumatology 29 (1), 70-86, 2019 | 45 | 2019 |
| Up-regulated expression of HLA-DRB5 transcripts and high frequency of the HLA-DRB5* 01: 05 allele in scleroderma patients with interstitial lung disease T Odani, S Yasuda, Y Ota, Y Fujieda, Y Kon, T Horita, Y Kawaguchi, ... Rheumatology 51 (10), 1765-1774, 2012 | 44 | 2012 |
| LAMP3 inhibits autophagy and contributes to cell death by lysosomal membrane permeabilization T Tanaka, BM Warner, DG Michael, H Nakamura, T Odani, H Yin, ... Autophagy 18 (7), 1629-1647, 2022 | 43 | 2022 |
| The short-term role of corticosteroid therapy for pulmonary arterial hypertension associated with connective tissue diseases: report of five cases and a literature review M Kato, H Kataoka, T Odani, Y Fujieda, K Otomo, K Oku, T Horita, ... Lupus 20 (10), 1047-1056, 2011 | 43 | 2011 |
| Clinical features of reversible posterior leukoencephalopathy syndrome in patients with systemic lupus erythematosus Y Fujieda, H Kataoka, T Odani, K Otomo, M Kato, S Fukaya, K Oku, ... Modern rheumatology 21 (3), 276-281, 2011 | 30 | 2011 |
| Lysosomal exocytosis of HSP70 stimulates monocytic BMP6 expression in Sjögren’s syndrome YQ Mo, H Nakamura, T Tanaka, T Odani, P Perez, Y Ji, BN French, ... The Journal of Clinical Investigation 132 (6), 2022 | 18 | 2022 |
| Autologous haematopoietic stem cell transplantation for Japanese patients with systemic sclerosis: Long-term follow-up on a phase II trial and treatment-related fatal … H Nakamura, T Odani, S Yasuda, A Noguchi, Y Fujieda, M Kato, K Oku, ... Modern rheumatology 28 (5), 879-884, 2018 | 18 | 2018 |
| Usefulness of tacrolimus for refractory adult-onset still's disease: Report of six cases H Nakamura, T Odani, Y Shimizu, T Takeda, H Kikuchi Modern rheumatology 26 (6), 963-967, 2016 | 16 | 2016 |
| Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan H Namkoong, R Edahiro, K Fukunaga, Y Shirai, K Sonehara, H Tanaka, ... medRxiv, 2021 | 15 | 2021 |
| Comprehensive and long-term surveys of COVID-19 sequelae in Japan, an ambidirectional multicentre cohort study: study protocol K Nakagawara, H Namkoong, H Terai, K Masaki, T Tanosaki, ... BMJ Open Respiratory Research 8 (1), e001015, 2021 | 14 | 2021 |
| The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force QS Wang, R Edahiro, H Namkoong, T Hasegawa, Y Shirai, K Sonehara, ... Nature Communications 13 (1), 1-19, 2022 | 13 | 2022 |
| A second update on mapping the human genetic architecture of COVID-19 M Kanai, SJ Andrews, M Cordioli, C Stevens, BM Neale, M Daly, A Ganna, ... Nature 621 (7977), E7-E26, 2023 | 12 | 2023 |
| An open-label, randomized controlled trial of sulfamethoxazole–trimethoprim for Pneumocystis prophylaxis: results of 52-week follow-up M Utsunomiya, H Dobashi, T Odani, K Saito, N Yokogawa, K Nagasaka, ... Rheumatology advances in practice 4 (2), rkaa029, 2020 | 10 | 2020 |
